NASDAQ
Aeolus Pharmaceuticals, Inc. (AOLS) has a current ratio of 4.25x as of Monday, May 25, 2026. This represents a 276.70% increase compared to its 12-month average of 1.13x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.